Strengths and Characteristics
The Kyorin Group's generic drug business is a secondary business to the ethical drugs business, and is expected to play a major role in the future. It is centered around KYORIN Rimedio Co., Ltd., which provides highly reliable generic drug products to complement the Group's core new drug business. By integrating its wholesale channels with those of KYORIN Pharmaceutical Co., Ltd., the company is working to make effective, efficient use of a broad wholesale network as part of its sales efforts.
Industry Trends
Aimed at containing health care costs, measures to promote the use of generic drugs have brought rapid growth to Japan's generic drug market. The government has announced a numeric goal calling for generic drugs to represent a greater than 30% share in volume by fiscal 2012, and the market is expected to expand further going forward. As the government continues to promote measures to contain healthcare costs, generic drug manufacturers will be expected to play a larger role in providing a stable supply of high-quality drugs, and to contribute to reigning in the cost of healthcare.
KYORIN Rimedio Co., Ltd.
KYORIN Rimedio Co., Ltd.(Japanese Only)
As the generic drug business subsidiary of the Kyorin Group, KYORIN Rimedio aims to become a highly reliable generic drug manufacturer. It will strive to improve product quality and win the trust of healthcare professionals, and to provide products that patients can use with confidence.
To respond to the growing needs for generic drugs at medical institutions and insurance dispensing pharmacies, and from other healthcare providers, KYORIN Rimedio will work to establish a brand with a reputation for reliability and safety. To do this, we will utilize our strengths, including production infrastructure that enables production of a wide range of formulations, and alliances within the Kyorin Group. We will also continue to aggressively promote alliances with domestic and overseas firms, enhancing our product lineup in specific fields, while working to reduce the cost of sales ratio and improve competitiveness.
To contribute to better patient health, and play a vital social role in containing healthcare costs and helping to maintain Japan’s social security infrastructure, KYORIN Rimedio will continue to ensure a stable supply of quality products and information, and to deliver distinctive, reliable generic drug products to the market as a generic drug company.
- Areas of Business :
- Research and development, Manufacturing, Sales
